Rituxan better than Fingolimod, Dymethyl fumarate and Natalizumab

A forum to discuss research on the origins of MS and its development.
Post Reply
User avatar
frodo
Family Elder
Posts: 1554
Joined: Wed Dec 02, 2009 3:00 pm
Contact:
Contact frodo

Rituxan better than Fingolimod, Dymethyl fumarate and Natalizumab

Post by frodo » Tue Aug 11, 2020 2:03 am

Rituxan better than Fingolimod, Dymethyl fumarate and Natalizumab

https://onlinelibrary.wiley.com/doi/ful ... acn3.51111

Interpretation

RTX demonstrated superior effectiveness and discontinuation outcomes compared to FTY and DMF. Although RTX demonstrated similar effectiveness and discontinuation compared to NTZ, RTX had superior effectiveness during months 6–24 and fewer discontinuations when excluding discontinuations due to insurance issues. Results suggest superiority of RTX in reducing disease activity and maintaining long‐term treatment in a real‐world MS cohort.
Top
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “MS Etiology and Pathogenesis”